首页 > 最新文献

Pleural and Mediastinal Malignancies最新文献

英文 中文
Predictors of pleurodesis success 胸膜固定术成功的预测因素
Pub Date : 2018-09-15 DOI: 10.1183/13993003.CONGRESS-2018.PA2881
R. Mercer, N. Speck, H. Jeffries, J. Macready, N. Kanellakis, N. Maskell, J. Pepperell, T. Saba, A. West, N. Ali, Robert F. Miller, J. Corcoran, R. Asciak, Maged Hassan, R. Hallifax, I. Psallidas, N. Rahman
Introduction: Patients with malignant pleural effusions (MPE) have a poor life expectancy and a high symptom burden. Definitive management strategies include chest drain and pleurodesis or placement of an indwelling pleural catheter. A meta analysis showed that 76% - 82% of patients had a successful pleurodesis with sterile talc. It has been postulated that patients who experience a greater inflammatory response or experience more pain are more likely to have a successful pleurodesis. Trapped lung is associated with a lower rate of pleurodesis success and it is thought that the number of previous interventions may be related to the development of trapped lung. Methods: A post hoc analysis from the TIME 1 trial was undertaken to establish the accuracy of these hypotheses. 320 patients were included who had a diagnosis of MPE. Results: There was a correlation between the number of previous ipsilateral aspirations and the incidence of trapped lung (p=0.015). Conclusion: Inflammation may play a factor in pleurodesis success as patients with a greater rise in CRP were more likely to have a successful pleurodesis. There is no evidence to support the hypothesis that patients who have more pain are more likely to have a successful pleurodesis. The correlation between the incidence of trapped lung and previous pleural interventions needs further study into whether or not there is a causal relationship.
恶性胸腔积液(MPE)患者预期寿命较差,症状负担高。最终的处理策略包括胸腔引流和胸膜清除率或放置留置胸膜导管。一项荟萃分析显示,76% - 82%的患者使用无菌滑石粉进行了成功的胸膜切除术。据推测,炎症反应更强烈或疼痛更严重的患者更有可能成功进行胸膜切除术。陷肺与较低的胸膜融合术成功率有关,以前的干预次数可能与陷肺的发展有关。方法:对TIME 1试验进行事后分析,以确定这些假设的准确性。320例诊断为MPE的患者纳入研究。结果:同侧入肺次数与陷肺发生率有相关性(p=0.015)。结论:炎症可能是胸膜穿刺术成功的一个因素,CRP升高越高的患者胸膜穿刺术成功的可能性越大。没有证据支持疼痛程度越高的患者越有可能成功进行胸膜切除术的假设。陷肺发生率与既往胸膜干预是否存在因果关系有待进一步研究。
{"title":"Predictors of pleurodesis success","authors":"R. Mercer, N. Speck, H. Jeffries, J. Macready, N. Kanellakis, N. Maskell, J. Pepperell, T. Saba, A. West, N. Ali, Robert F. Miller, J. Corcoran, R. Asciak, Maged Hassan, R. Hallifax, I. Psallidas, N. Rahman","doi":"10.1183/13993003.CONGRESS-2018.PA2881","DOIUrl":"https://doi.org/10.1183/13993003.CONGRESS-2018.PA2881","url":null,"abstract":"Introduction: Patients with malignant pleural effusions (MPE) have a poor life expectancy and a high symptom burden. Definitive management strategies include chest drain and pleurodesis or placement of an indwelling pleural catheter. A meta analysis showed that 76% - 82% of patients had a successful pleurodesis with sterile talc. It has been postulated that patients who experience a greater inflammatory response or experience more pain are more likely to have a successful pleurodesis. Trapped lung is associated with a lower rate of pleurodesis success and it is thought that the number of previous interventions may be related to the development of trapped lung. Methods: A post hoc analysis from the TIME 1 trial was undertaken to establish the accuracy of these hypotheses. 320 patients were included who had a diagnosis of MPE. Results: There was a correlation between the number of previous ipsilateral aspirations and the incidence of trapped lung (p=0.015). Conclusion: Inflammation may play a factor in pleurodesis success as patients with a greater rise in CRP were more likely to have a successful pleurodesis. There is no evidence to support the hypothesis that patients who have more pain are more likely to have a successful pleurodesis. The correlation between the incidence of trapped lung and previous pleural interventions needs further study into whether or not there is a causal relationship.","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89392005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and histological analysis of malignant mesothelioma - a comprehensive state-wide study 恶性间皮瘤的临床和组织学分析——一项全面的全国性研究
Pub Date : 2018-09-15 DOI: 10.1183/13993003.congress-2018.pa2884
Nicola Pferdmenges, V. Krieg, A. Schulze, H. Kajueter, G. Evers, M. Mohr, L. Schmidt, H. Hense, O. Heidinger, R. Wiewrodt
Background: The cancer registry Northrhine-Westphalia (CR NRW) is state-law based, prospective cancer registry, including all state residents with the diagnosis of cancer (NRW counts approx. 18 million residents). Methods: All MM cases diagnosed and collected between 2010 and 2012 in CR NRW were included (n=1199). 232 cases contained incomplete datasets. In 755 of 967 valid cases (78.1%) the original pathology report was visible, in 468 cases (48.4%) including immunohistochemistry. Results: Of 967 patients with MM 796 were male (82.3%) and 171 female (17.7%), 81.8% were already diseased upon last validation date. Based on ICD-codes 885 patients (91.5%) suffered from pleural MM (C45.0), 72 (7.4%) had peritoneal MM, 2 (0.2%) pericardial MM and 8 (0.8%) had various MM locations. Histology showed predominantly epithelioid growing pattern (60.4%), followed by biphasic growth (13.4%) and sarcomatoid growth (9.4%); in 16.8% the growing pattern was not defined. Median overall survival (OS) of pleural MM was 12.4 months (95%KI 11.3-13.4; all histologies), OS of peritoneal MM was 15.1 months (95%KI 4.5-25.7; all histologies). Multivariate analysis revealed gender, age, histological subtype, cell specific growing features (spindle cell type; papillary type), necrosis, hyaline plaques and proliferation marker Ki67 as independent prognostic factors (p Conclusion: The comprehensive, state-law embedded cancer registry NRW ensures the complete area-wide identification and collection of cancer patients’ course out of 18 million residents. In this very large study MM cell specific growing features and proliferation index could be identified as new independent markers of MM outcome.
背景:北威斯特伐利亚州(CR NRW)癌症登记处是一个以州法律为基础的前瞻性癌症登记处,包括所有诊断为癌症的州居民(NRW计数约为1。1800万居民)。方法:选取2010 ~ 2012年在北威州诊断并收集的所有MM病例(n=1199例)。232例包含不完整的数据集。在967例有效病例中,755例(78.1%)可见原始病理报告,468例(48.4%)包括免疫组织化学。结果:967例MM 796患者中,男性占82.3%,女性占171例(17.7%),其中81.8%在最后验证日已经患病。根据icd编码,885例(91.5%)患者为胸膜MM (C45.0), 72例(7.4%)为腹膜MM, 2例(0.2%)为心包MM, 8例(0.8%)为不同部位MM。组织学以上皮样生长为主(60.4%),其次为双相生长(13.4%)和肉瘤样生长(9.4%);16.8%的人生长模式不明确。胸膜MM的中位总生存期(OS)为12.4个月(95%KI为11.3-13.4;所有组织学),腹膜MM的OS为15.1个月(95%KI 4.5-25.7;所有组织学)。多变量分析显示性别、年龄、组织学亚型、细胞特异性生长特征(梭形细胞类型;结论:全面的、嵌入国家法律的癌症登记处NRW确保了1800万居民中完整的全区域癌症患者病程的识别和收集。在这项非常大规模的研究中,MM细胞特异性生长特征和增殖指数可以被确定为MM预后的新的独立标志物。
{"title":"Clinical and histological analysis of malignant mesothelioma - a comprehensive state-wide study","authors":"Nicola Pferdmenges, V. Krieg, A. Schulze, H. Kajueter, G. Evers, M. Mohr, L. Schmidt, H. Hense, O. Heidinger, R. Wiewrodt","doi":"10.1183/13993003.congress-2018.pa2884","DOIUrl":"https://doi.org/10.1183/13993003.congress-2018.pa2884","url":null,"abstract":"Background: The cancer registry Northrhine-Westphalia (CR NRW) is state-law based, prospective cancer registry, including all state residents with the diagnosis of cancer (NRW counts approx. 18 million residents). Methods: All MM cases diagnosed and collected between 2010 and 2012 in CR NRW were included (n=1199). 232 cases contained incomplete datasets. In 755 of 967 valid cases (78.1%) the original pathology report was visible, in 468 cases (48.4%) including immunohistochemistry. Results: Of 967 patients with MM 796 were male (82.3%) and 171 female (17.7%), 81.8% were already diseased upon last validation date. Based on ICD-codes 885 patients (91.5%) suffered from pleural MM (C45.0), 72 (7.4%) had peritoneal MM, 2 (0.2%) pericardial MM and 8 (0.8%) had various MM locations. Histology showed predominantly epithelioid growing pattern (60.4%), followed by biphasic growth (13.4%) and sarcomatoid growth (9.4%); in 16.8% the growing pattern was not defined. Median overall survival (OS) of pleural MM was 12.4 months (95%KI 11.3-13.4; all histologies), OS of peritoneal MM was 15.1 months (95%KI 4.5-25.7; all histologies). Multivariate analysis revealed gender, age, histological subtype, cell specific growing features (spindle cell type; papillary type), necrosis, hyaline plaques and proliferation marker Ki67 as independent prognostic factors (p Conclusion: The comprehensive, state-law embedded cancer registry NRW ensures the complete area-wide identification and collection of cancer patients’ course out of 18 million residents. In this very large study MM cell specific growing features and proliferation index could be identified as new independent markers of MM outcome.","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81534344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparison of outcomes from a regional Mesothelioma MDT against the National Lung Cancer Audit (NLCA) Mesothelioma standards 区域性间皮瘤MDT与国家肺癌审计(NLCA)间皮瘤标准结果的比较
Pub Date : 2018-09-15 DOI: 10.1183/13993003.CONGRESS-2018.PA2889
Maryam Ahmed, J. Lyons, S. Jackson, A. Sharman, M. Dixon, P. Taylor, J. Holme, M. Evison
Background: Malignant mesothelioma (MM) is an incurable malignancy with a poor prognosis. In 2014, 43% of patients survived to one year following diagnosis in the UK. There is evidence of patient benefit from regional mesothelioma multidisciplinary team meetings1. The 2016 NLCA Pleural Mesothelioma report defined key recommendations for patients diagnosed with MM in England in 2014. Aims: To evaluate and compare outcomes of patients managed through the Greater Manchester Regional Mesothelioma MDT against the 2016 NLCA findings. Methods: Retrospective review of MM cases discussed at our MDT meeting between April 2016 and February 2018 using data from electronic MDT proformas. Results: Conclusions: Outcomes from our MDT are encouraging and may help build evidence in favour of regional mesothelioma MDTs. In particular, active treatment rates and ensuring equity of access to clinical research appears higher than national figures within this specialist service. References: 1. Bibby, Anna C et al. “What Is the Role of a Specialist Regional Mesothelioma Multidisciplinary Team Meeting? A Service Evaluation of One Tertiary Referral Centre in the UK.” BMJ Open 6.9 (2016): e012092.
背景:恶性间皮瘤(MM)是一种无法治愈的恶性肿瘤,预后不良。2014年,在英国,43%的患者在确诊后存活到一年。有证据表明,区域性间皮瘤多学科小组会议对患者有益。2016年NLCA胸膜间皮瘤报告确定了2014年英国诊断为MM的患者的关键建议。目的:评估和比较通过大曼彻斯特地区间皮瘤MDT治疗的患者的结果与2016年NLCA研究结果。方法:回顾性分析2016年4月至2018年2月MDT会议上讨论的MM病例,使用MDT电子表格的数据。结论:我们的MDT的结果是令人鼓舞的,可能有助于建立支持区域间皮瘤MDT的证据。特别是,在这一专业服务中,积极治疗率和确保公平获得临床研究似乎高于全国数字。引用:1。Bibby, Anna C等人,“区域间皮瘤多学科专家小组会议的作用是什么?”英国一家高等教育转诊中心的服务评估。BMJ Open 6.9 (2016): e012092。
{"title":"A comparison of outcomes from a regional Mesothelioma MDT against the National Lung Cancer Audit (NLCA) Mesothelioma standards","authors":"Maryam Ahmed, J. Lyons, S. Jackson, A. Sharman, M. Dixon, P. Taylor, J. Holme, M. Evison","doi":"10.1183/13993003.CONGRESS-2018.PA2889","DOIUrl":"https://doi.org/10.1183/13993003.CONGRESS-2018.PA2889","url":null,"abstract":"Background: Malignant mesothelioma (MM) is an incurable malignancy with a poor prognosis. In 2014, 43% of patients survived to one year following diagnosis in the UK. There is evidence of patient benefit from regional mesothelioma multidisciplinary team meetings1. The 2016 NLCA Pleural Mesothelioma report defined key recommendations for patients diagnosed with MM in England in 2014. Aims: To evaluate and compare outcomes of patients managed through the Greater Manchester Regional Mesothelioma MDT against the 2016 NLCA findings. Methods: Retrospective review of MM cases discussed at our MDT meeting between April 2016 and February 2018 using data from electronic MDT proformas. Results: Conclusions: Outcomes from our MDT are encouraging and may help build evidence in favour of regional mesothelioma MDTs. In particular, active treatment rates and ensuring equity of access to clinical research appears higher than national figures within this specialist service. References: 1. Bibby, Anna C et al. “What Is the Role of a Specialist Regional Mesothelioma Multidisciplinary Team Meeting? A Service Evaluation of One Tertiary Referral Centre in the UK.” BMJ Open 6.9 (2016): e012092.","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88970520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Cytology, chest computed and positron emission tomography correlations in lung cancer malignant pleural effusion. 肺癌恶性胸腔积液的细胞学、胸部计算机和正电子发射断层扫描的相关性。
Pub Date : 2018-09-15 DOI: 10.1183/13993003.congress-2018.pa2867
C. Brun, M. Cottier, G. Karpathiou, F. Barral, J. Vergnon, M. Froudarakis
{"title":"Cytology, chest computed and positron emission tomography correlations in lung cancer malignant pleural effusion.","authors":"C. Brun, M. Cottier, G. Karpathiou, F. Barral, J. Vergnon, M. Froudarakis","doi":"10.1183/13993003.congress-2018.pa2867","DOIUrl":"https://doi.org/10.1183/13993003.congress-2018.pa2867","url":null,"abstract":"","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80110547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determinants of survival in patients with malignant pleural mesothelioma (MPM) managed at a single institution in Liguria, Italy 在利古里亚单一机构管理的恶性胸膜间皮瘤(MPM)患者生存的决定因素
Pub Date : 2018-09-15 DOI: 10.1183/13993003.congress-2018.pa2880
A. Carletti, L. Benfatto, Vanna Balestracci, P. Canessa
{"title":"Determinants of survival in patients with malignant pleural mesothelioma (MPM) managed at a single institution in Liguria, Italy","authors":"A. Carletti, L. Benfatto, Vanna Balestracci, P. Canessa","doi":"10.1183/13993003.congress-2018.pa2880","DOIUrl":"https://doi.org/10.1183/13993003.congress-2018.pa2880","url":null,"abstract":"","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86759704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iodopovidone pleurodesis, diferent techniques, excellent efficacy in malignant pleural effusion.. Tanta University experience 碘聚维酮胸膜融合术,技术不同,治疗恶性胸腔积液疗效优异。坦塔大学经历
Pub Date : 2018-09-15 DOI: 10.1183/13993003.CONGRESS-2018.PA2885
R. Sharshar
{"title":"Iodopovidone pleurodesis, diferent techniques, excellent efficacy in malignant pleural effusion.. Tanta University experience","authors":"R. Sharshar","doi":"10.1183/13993003.CONGRESS-2018.PA2885","DOIUrl":"https://doi.org/10.1183/13993003.CONGRESS-2018.PA2885","url":null,"abstract":"","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80279889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Needle Based Confocal Laser Endomicroscopy (nCLE) for Diagnosing Malignant Pleural Mesothelioma 针基共聚焦激光内镜诊断恶性胸膜间皮瘤
Pub Date : 2018-09-15 DOI: 10.1183/13993003.CONGRESS-2018.OA496
L. Wijmans, M. Disselhorst, D. M. Bruin, J. Roelofs, O. Mets, P. Bonta, P. Baas, J. Annema
{"title":"Needle Based Confocal Laser Endomicroscopy (nCLE) for Diagnosing Malignant Pleural Mesothelioma","authors":"L. Wijmans, M. Disselhorst, D. M. Bruin, J. Roelofs, O. Mets, P. Bonta, P. Baas, J. Annema","doi":"10.1183/13993003.CONGRESS-2018.OA496","DOIUrl":"https://doi.org/10.1183/13993003.CONGRESS-2018.OA496","url":null,"abstract":"","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81722038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pericardial and pleural metastases: clinical and histological differences 心包和胸膜转移:临床和组织学差异
Pub Date : 2018-09-15 DOI: 10.1183/13993003.congress-2018.pa2874
G. Karpathiou, Mousa Mobarki, Sirine Hathroubi, M. Stachowicz, A. Patoir, O. Tiffet, M. Péoc'h, M. Froudarakis
{"title":"Pericardial and pleural metastases: clinical and histological differences","authors":"G. Karpathiou, Mousa Mobarki, Sirine Hathroubi, M. Stachowicz, A. Patoir, O. Tiffet, M. Péoc'h, M. Froudarakis","doi":"10.1183/13993003.congress-2018.pa2874","DOIUrl":"https://doi.org/10.1183/13993003.congress-2018.pa2874","url":null,"abstract":"","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90721666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival of patients with malignant pleural effusions: a three-year prospective self-experience study 恶性胸腔积液患者的生存率:一项为期三年的前瞻性自我体验研究
Pub Date : 2018-09-15 DOI: 10.1183/13993003.congress-2018.pa2890
I. Novakov, Filip Sterev
{"title":"Survival of patients with malignant pleural effusions: a three-year prospective self-experience study","authors":"I. Novakov, Filip Sterev","doi":"10.1183/13993003.congress-2018.pa2890","DOIUrl":"https://doi.org/10.1183/13993003.congress-2018.pa2890","url":null,"abstract":"","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74711061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between baseline metabolic 18F-FDG parameters and survival in malignant pleural mesothelioma: A single centre experience 恶性胸膜间皮瘤患者基线代谢18F-FDG参数与生存率的关系:单中心经验
Pub Date : 2018-09-15 DOI: 10.1183/13993003.congress-2018.pa2888
Y. Kahya, Ç. Soydal, M. Yenigün, E. Ozkan, N. A. Tutkun, S. Enön, N. O. Kucuk, A. Cangır
{"title":"Relationship between baseline metabolic 18F-FDG parameters and survival in malignant pleural mesothelioma: A single centre experience","authors":"Y. Kahya, Ç. Soydal, M. Yenigün, E. Ozkan, N. A. Tutkun, S. Enön, N. O. Kucuk, A. Cangır","doi":"10.1183/13993003.congress-2018.pa2888","DOIUrl":"https://doi.org/10.1183/13993003.congress-2018.pa2888","url":null,"abstract":"","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77183777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pleural and Mediastinal Malignancies
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1